Tech Company Financing Transactions

Wright Medical Funding Round

Noro-Moseley Partners, Axiom Venture Partners and Burrill & Company joined a $11.8 million Series C venture round for Wright Medical. This venture round closed on 5/18/2005.

Transaction Overview

Company Name
Wright Medical
Announced On
5/18/2005
Transaction Type
Venture Equity
Amount
$11,800,000
Round
Series C
Investors

Noro-Moseley Partners (Lead Investor) (Rusty French)

Axiom Venture Partners

Burrill & Company

InterWest Partners

Presidio Partners

Proceeds Purpose
The funds raised in this financing will also be used to build commercial inventory for the Company's lead product candidate GEM 21S , being developed for the treatment of bone defects in the jaw and maxillofacial region, add key personnel, and expand the Company's corporate facilities to include research and development space.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1023 Cherry Rd.
Memphis, TN 38117
USA
Phone
901-867-9971
Website
www.wright.com
Email Address
[email protected]
Overview
Wright Medical is a global specialty orthopaedic medical device company providing extremity & biologic solutions.
Profile
Wright Medical LinkedIn Company Profile
Social Media
Wright Medical Company Twitter Account
Company News
Wright Medical News
Facebook
Wright Medical on Facebook
YouTube
Wright Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Samuel Lynch
  Samuel Lynch LinkedIn Profile  Samuel Lynch Twitter Account  Samuel Lynch News  Samuel Lynch on Facebook
Chief Financial Officer
Larry Bullock
  Larry Bullock LinkedIn Profile  Larry Bullock Twitter Account  Larry Bullock News  Larry Bullock on Facebook
VP - Marketing
Scott Ludecker
  Scott Ludecker LinkedIn Profile  Scott Ludecker Twitter Account  Scott Ludecker News  Scott Ludecker on Facebook
VP - Operations
James Monsor
  James Monsor LinkedIn Profile  James Monsor Twitter Account  James Monsor News  James Monsor on Facebook
VP - R & D
Leo Snel
  Leo Snel LinkedIn Profile  Leo Snel Twitter Account  Leo Snel News  Leo Snel on Facebook
VP - Regulatory Affairs
Russ Pagano
  Russ Pagano LinkedIn Profile  Russ Pagano Twitter Account  Russ Pagano News  Russ Pagano on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/18/2005: Azelon Pharmaceuticals venture capital transaction
Next: 5/19/2005: Gemin X Pharmaceuticals venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.